The novel phosphoinositide 3-kinase-mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor.
| Image |  |
|---|---|
| Description | scientific article published on 12 February 2013 |
| Author/s |
author: Tadaaki Yamada Kunio Matsumoto |
| Publication date | February 12, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |